Craig A Johnson
CIK 1370348 · Sr. VP, CFO and Secretary · last filed 2026-06-08
Craig A Johnson is a Sr. VP, CFO and Secretary who has filed 72 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for AUPH, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $252.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$252.4K
6
72
-$5.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Director | 14,592 | $15.82 | $230.8K | $0 | 4 | 2026-06-08 |
| HRTX | Director | 53,960 | $0.40 | $21.6K | -$13.6K | 18 | 2026-02-03 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 0 | $58.70 | $0 | -$5.61M | 16 | 2024-01-23 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | 12,000 | $6.22 | $74.6K | $0 | 11 | 2022-07-12 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 3,000 | $1.12 | $3.4K | $51.0K | 5 | 2020-12-31 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | 1,000 | — | — | -$75.7K | 8 | 2012-06-20 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | HRTX | Grant (A) | +53,960 | $0 | EDGAR |
| 2025-11-24 | AUPH | Tax (F) | −6,039 | -$94.7K | EDGAR |
| 2025-05-16 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | HRTX | Grant (A) | +17,950 | $0 | EDGAR |
| 2025-02-03 | HRTX | Grant (A) | +17,950 | $0 | EDGAR |
| 2024-11-25 | AUPH | Grant (A) | +20,631 | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −17,273 | $0 | EDGAR |
| 2024-01-19 | HRTX | Grant (A) | +13,948 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +6,808 | $400.0K | EDGAR |